Francesco Rodeghiero

Author

Also Known As

Bettina Gisslinger, D Turri, Emma Cacciola, F Rodeghiero, F. RODEGHIERO, F. Rodeghiero, FRANCESCO RODEGHIERO, Francesco Rodeghiero, Giancarlo Castaman, P Ridker

167

Publications

11.2K

Citations

H-Index

Concepts

All Affiliations

Ospedale San Bortolo University of Florence University of Padua University of Bergamo Medical University of Vienna

About

Francesco Rodeghiero is an author at Ospedale San Bortolo specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	2K
2	Public Health	11	11	1.5K
3	Health Sciences	4	4	113
4	Engineering	1	1	16
5	Natural Sciences	1	1	16

Francesco Rodeghiero

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis Sergio Cortelazzo, Guido Finazzi, Marco Ruggeri, New England Journal of Medicine	1995	840
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Ayalew Tefferi, Elisa Rumi, Guido Finazzi, Leukemia	2013	653
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Miguel Á. Sanz, Francesco Lo‐Coco, Giuseppe Avvisati, PubMed	2000	632
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) Tiziano Barbui, Guido Finazzi, Alessandra Carobbio, Blood	2012	575
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study Tiziano Barbui, Jüergen Thiele, Francesco Passamonti, Journal of Clinical Oncology	2011	531
Impact, Diagnosis and Treatment of von Willebrand Disease J. Evan Sadler, Erik Berntorp, Victor Boulyjenkov, Thrombosis and Haemostasis World Health OrganizationVon Willebrand DiseaseThrombosisClinical FindingVenous Thrombosis	2000	501
Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Sergio Cortelazzo, Piera Viero, Guido Finazzi, Journal of Clinical Oncology HypertensionEssential ThrombocythemiaMajor Risk FactorsThrombosisVenous Thrombosis	1990	468
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti, Blood	2011	440
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments Valerio De Stefano, Tommaso Zà, E. Rossi, Haematologica	2008	352
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment Francesco Passamonti, Jürgen Thiele, François Girodon, Blood	2012	260

Page 1